Starton Therapeutics Inc. (“Starton” or the “Company”) today announced that Pedro Lichtinger, Chairman and Chief Executive Officer of Starton Therapeutics, will present and host one-on-one meetings at the BIO CEO & Investor Conference being held in New York City, February 26-27, 2024.
February 23, 2024
· 1 min read
